287 related articles for article (PubMed ID: 19244121)
21. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
22. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
[TBL] [Abstract][Full Text] [Related]
23. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
24. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
25. Liposomal transfection of squamous carcinoma cells of the head and neck with IL-2 and B7 plasmids inducing an autologous immune response in vitro.
Mayer A; Andratschke M; Pauli C; Reitberger E; Kolbow K; Wollenberg B
Anticancer Res; 2005; 25(6B):3917-23. PubMed ID: 16309178
[TBL] [Abstract][Full Text] [Related]
26. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
27. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
28. Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression.
Torrero MN; Xia X; Henk W; Yu S; Li S
Cancer Res; 2006 Apr; 66(8):4461-7. PubMed ID: 16618773
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18.
Moore MB; Kurago ZB; Fullenkamp CA; Lutz CT
Cancer Immunol Immunother; 2003 Feb; 52(2):107-15. PubMed ID: 12594574
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
[TBL] [Abstract][Full Text] [Related]
31. AK-5 tumor-induced expression of interleukin-12: role of IL-12 in NK-mediated AK-5 regression.
Hegde SP; Bright JJ; Kausalya S; Khar A
Cell Immunol; 1995 May; 162(2):241-7. PubMed ID: 7743551
[TBL] [Abstract][Full Text] [Related]
32. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
33. A murine model for the immunotherapy of head and neck squamous cell carcinoma.
Hier MP; Black MJ; Shenouda G; Sadeghi N; Karp SE
Laryngoscope; 1995 Oct; 105(10):1077-80. PubMed ID: 7564839
[TBL] [Abstract][Full Text] [Related]
34. The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets.
Sung MW; Nagashima S; Johnson JT; Van Dongen GA; Whiteside TL
Cell Immunol; 1996 Jul; 171(1):20-9. PubMed ID: 8660833
[TBL] [Abstract][Full Text] [Related]
35. The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck.
Kim CD; Sung MW; Lee SJ; Heo DS; Yoon SJ; Kim KH
Anticancer Res; 1999; 19(1A):455-9. PubMed ID: 10226582
[TBL] [Abstract][Full Text] [Related]
36. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa.
Kodama N; Asakawa A; Inui A; Masuda Y; Nanba H
Oncol Rep; 2005 Mar; 13(3):497-502. PubMed ID: 15706424
[TBL] [Abstract][Full Text] [Related]
38. Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells.
Konstantinidis KV; Alici E; Aints A; Christensson B; Ljunggren HG; Dilber MS
Exp Hematol; 2005 Feb; 33(2):159-64. PubMed ID: 15676209
[TBL] [Abstract][Full Text] [Related]
39. Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma.
Xian J; Yang H; Lin Y; Liu S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1079-85. PubMed ID: 16365221
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha enhances IL-15-induced natural killer cell differentiation.
Lee J; Lee SH; Shin N; Jeong M; Kim MS; Kim MJ; Yoon SR; Chung JW; Kim TD; Choi I
Biochem Biophys Res Commun; 2009 Sep; 386(4):718-23. PubMed ID: 19559672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
